The startup intends to make a small patch pump with a closed-loop algorithm for nighttime glucose control.

Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.

The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.